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ABSTRACT 
 
 
Purpose 
 
The study was conducted to compare intralesional methylprednisolone acetate 40 mg/ml 
(Depo-Medrol) injection with incision and curettage in the treatment of chalazia. 
 
 
Method 
 
A prospective, interventional clinical study was conducted. Seventy-seven patients that 
met the inclusion criteria and gave informed consent were randomized to receive either 
intralesional methylprednisolone injection or incision and curettage. Patients were 
followed up at two weeks and at one month, and the treatment was repeated when 
indicated. 
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Results 
 
Seventy-three patients completed the study. At two weeks, after one treatment, there was 
a significant difference in outcome (p = 0.002) between the two groups: 10 (27%) 
chalazia resolved after intralesional methylprednisolone injection and 23 (64%) after 
incision and curettage. At one month however, there was no statistical difference (p = 
0.223) in outcome between the two groups: resolution occurred in 24 patients (65%) after 
intralesional methylprednisolone injection, and in 28 patients (78%) after incision and 
curettage. In cases that were successfully treated at one month, 58% required a second 
treatment with intralesional injection, which was significantly more (p = 0.020) than the 
18% with incision and curettage. In both groups, the initial chalazion size and duration 
did not significantly influence the outcome of treatment. The average time to perform 
intralesional injection (39 seconds) was significantly quicker (p = 0.000) than the average 
time for incision and curettage (2 minutes 46 seconds). In 3 out of 37 injected patients, a 
slight subcutaneous methylprednisolone deposit was visible at one month. 
 
 
Conclusion 
 
Incision and curettage remains the gold standard in the treatment of chalazia, but 
intralesional methylprednisolone (Depo-Medrol) injection is an useful alternative 
treatment modality. 
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PREFACE 
 
 
I first became interested in treating chalazia with corticosteroid injections when an article 
was presented at our journal club where a group of patients in America were effectively 
treated with intralesional triamcinolone 40 mg/ml injection. 
 
With triamcinolone not being readily available at St John, I wondered if I could not use 
an alternative corticosteroid. A Pubmed search revealed a study from Poland where 
methylprednisolone 40 mg/ml (Depo-Medrol) injection was used. 
 
Depo-Medrol is readily available at St John, and I decided in future to give patients with 
chalazia a treatment option with intralesional Depo-Medrol injection. This treatment 
seemed to work quite well, and I thought it would be a good idea to do a formal study to 
determine its effectiveness in our patients.   
 
I then discussed the idea with Professor Carmichael who suggested that it would be best 
to compare intralesional injection with incision and curettage, which is regarded by most 
ophthalmologists as the gold standard in the treatment of chalazia. 
 
 
This is the first randomized controlled trial where intralesional  
 
methylprednisolone injection was compared  with incision and curettage in the treatment 
 
of chalazia. 
 
1.0  INTRODUCTION 
 
 
A chalazion or meibomian cyst (Figure 1.1) is a benign eyelid nodule that is commonly 
treated by ophthalmologists and general practitioners. 
 
Figure 1.1: Left upper lid chalazion 
 
 
 
 
A chalazion is caused by blockage of the meibomian gland orifices, which open on the lid 
margins behind the eyelashes. Blockage is most often caused by underlying obstructive 
meibomian gland dysfunction,(1) but can also be caused by subepithelial scarring in 
cicatricial conjunctivitis. Stagnation of meibomian gland secretions leads to the formation 
of this chronic, sterile, lipogranulomatous inflammatory eyelid nodule. The granuloma 
usually contains epithelioid and giant cells, but lymphocytes, neutrophils and eosinophils 
may also be present.  
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Apart from cosmetic disfigurement, a chalazion can also cause irritation, discomfort, 
corneal astigmatism and mechanical ptosis. 
 
Treatment options include excision, incision and curettage, intralesional and extralesional 
corticosteroid injection and conservative therapy with hot compresses, eyelid hygiene and 
antibiotics. 
 
This study was done to compare intralesional methylprednisolone acetate 40 mg/ml 
(Depo-Medrol) injection with incision and curettage in the treatment of chalazia. In a 
number of previous comparative studies, intralesional triamcinolone injection as well as 
incision and curettage proved to be effective treatment modalities for chalazia. (2; 3; 4; 5; 6) 
Chalazia in a group of Polish patients were previously effectively treated with 
intralesional methylprednisolone injection.  No adverse effects were reported in this 
study.(7) 
 
Methylprednisolone is a corticosteroid that is commonly used to treat inflamed joints and 
various inflammatory skin lesions. A chalazion is a sterile, inflammatory eyelid nodule, 
and for this reason is sensitive to the anti-inflammatory effect of corticosteroids. 
Methylprednisolone was chosen because it is a corticosteroid that is, unlike 
triamcinolone, readily available at our hospitals. Incision and curettage is the 
conventional method of treatment for chalazia, and is regarded by most ophthalmologists 
as the standard surgical management and gold standard of treatment. Other treatment 
modalities should be compared with this method. 
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2.0  LITERATURE REVIEW 
 
 
Corticosteroid injection for the treatment of chalazia was first used in 1964.(8) Since then, 
various clinical trials have investigated the use of corticosteroid injection in the treatment 
of chalazia. 
 
 
 Intralesional triamcinolone injection compared with incision and curettage 
 
In a number of previous studies, intralesional triamcinolone injection was compared with 
incision and curettage.(2; 3; 4; 5; 6)   
 
Jacobs (2) reported a 60% cure rate after a single incision and curettage procedure and an 
8.7% cure rate after a single intralesional triamcinolone hexacetonide injection (5 mg/ml, 
0.05 – 0.2 ml).  
 
Watson (3) reported a 90% cure rate with incision and curettage and a 77% cure rate with 
intralesional injection of triamcinolone acetonide (10 mg/ml, 0.02 – 0.2 ml). Of the 
surgically treated cases, 27% required a second procedure while 54% of cases treated 
with injection required a second procedure.  
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Khurana (4) reported an 88% cure rate with incision and curettage and a 61% cure rate 
with intralesional triamcinolone acetonide injection (10 mg/ml, 0.02 – 0.2 ml) for 
chalazia up to 7 mm in diameter. The larger chalazia (8 – 12 mm in diameter) did not 
respond to intralesional triamcinolone injection but were effectively treated with incision 
and curettage. 
  
Mustafa (5) reported a cure rate of 75% after a single treatment with incision and 
curettage. The cure rate was the same after a single triamcinolone acetonide 5 mg/ml 
injection. 
 
Prasad (6) also reported a similar cure rate with these two methods - 75% after 
triamcinolone acetonide injection (20 mg/ml, 0.2 ml) and 76% after incision and 
curettage. 
 
 
Intra and extralesional triamcinolone injection 
 
Intralesional triamcinolone injection (0.05 - 0.5 ml, 5 – 40 mg/ml ) has been used with 
success in 76% - 92% of cases within 2 - 4 weeks.(9; 10; 11; 12) After a single injection the 
cure rates were 60% and 41%.(9; 12)  
 
Ho (13) investigated the use of extralesional triamcinolone injection, and reported a 54% 
cure rate after one injection and a 90% cure rate after two injections.  
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The duration (9; 10; 13)   and size (13) of the chalazia did not significantly influence the 
outcome of treatment. Of the patients that were successfully treated, 33% - 44% needed a 
second or third injection.(9; 11; 12; 13) 
 
 
Intralesional methylprednisolone injection 
 
Kaminska (7) treated chalazia of a 2 week to 6 year duration with intralesional injection of 
methylprednisolone acetate 40 mg/ml (Depo-Medrol). The size of the chalazia varied 
between 3 mm and 20 mm. Thirty chalazia (52%) resolved after one injection and 86% 
after a second injection given 2 weeks later. No complications occurred. 
 
 
Intralesional dexamethasone injection 
 
Gercowicz (14) used intralesional dexamethasone (4 mg/ml) and reported an 83% cure rate 
for chalazia of a duration of less than 3 months. Two to three injections were given and 
resolution occurred over a 2 - 3 week period. Chalazia older than 3 months showed a 
poor response to treatment. 
 
Verdeaux (15) reported a 38% success rate one week after a single injection of 
dexamethasone phosphate. No further injections were given in this trial. The authors 
concluded that corticosteroid injection was more effective in acute forms of chalazia. 
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Possible adverse effects of corticosteroid injection  
 
Corticosteroid injection is considered to be a safe and effective form of treatment, but 
adverse effects after treatment have been reported. Small subcutaneous white deposits 
were visible in 2 of 23 patients after transconjunctival intralesional injection.(2)  Yellow 
deposits at the injection site occurred in 2 of 12 cases after transcutaneous intralesional 
injection.(5) A yellow eyelid deposit developed at the injection site in 1 of 17 cases after 
transcutaneous intralesional injection.(12)  Skin depigmentation at the injection site 
occurred in 2 out of 48 patients after extralesional injection.(13)  
 
Crystalline or insoluble corticosteroid preparations (“Depo” forms) may be more likely to 
cause permanent dermis atrophy than soluble aqueous corticosteroid preparations. Skin 
changes are almost always temporary, and the appearance of the skin returns to normal 
within several months.(12) 
 
Other rare complications that have been reported are retinal and choroidal vascular 
occlusion (16) and corneal penetration.(17) Increased intraocular pressure after 
subconjunctival corticosteroid administration has also been reported.(18) 
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Advantages of corticosteroid injection 
 
Advantages include the following: 
• It is a quick, cheap and simple procedure. 
• Unlike incision and curettage, no special instruments are required. Minimal 
bleeding occurs and there is no need to apply an eye pad. Bilateral cases can 
conveniently be treated at the same visit. Investigators report that patients 
experience no greater  pain than with a local anaesthetic injection.(12) 
• It may be a more suitable treatment modality for multiple small chalazia, marginal 
chalazia and those near the lacrimal drainage system. There is a low risk of 
damaging eyelid structures. 
• For some patients it may be a less frightening treatment option that will cause 
them less  distress and discomfort. 
• Surgery can be avoided. 
 
 
Incision and curettage 
 
Kaimbo (19) treated 30 chalazia in African patients with incision and curettage, and 
achieved a 100% cure rate. A successful outcome was defined as a decrease in chalazion 
size to less than 1 mm. Recurrence was seen in 3% of cases at 5 weeks. 
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3.0  PATIENTS AND METHODS 
 
 
A prospective clinical study was conducted. Seventy-seven consecutive patients, that met 
the inclusion criteria and gave informed consent, were randomized to receive either 
intralesional methylprednisolone acetate 40 mg/ml (Depo-Medrol) injection or incision 
and curettage. As the patients presented they received the next available study file. 
Patient files are numbered consecutively. Patients that received a study file with an odd 
last number were given intralesional injection while patients that received a file with an 
even last number were given incision and curettage. 
 
All chalazia older than one month, without signs of infection and without a history of 
previous treatment (except conservative treatment) were included in the study. The 
patients were recruited at St  John and at Helen Joseph  from January 2006 to July 2006. 
Patients were followed up at two weeks and at one month. Treatment was repeated after 
two weeks if the chalazion was not cured. A chalazion was defined as cured if there was 
no visible external lesion after treatment. If treatment was unsuccessful at the second 
follow-up visit at one month, the patient was offered the alternative method of treatment. 
 
Duration and possible previous treatment of the chalazia were documented. Lesion size 
was measured with a caliper along the largest diameter of the lesion and the chalazion 
was charted on a drawing of the eyelids. The patients were examined for possible 
associated acne rosacea. Lesion size, visual acuity and intraocular pressure were 
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measured before treatment and at follow-up visits. Digital colour photographs were taken 
at each visit. The time taken to perform each procedure was measured with a stopwatch. 
Patients were monitored for skin changes and other possible complications of treatment.  
 
Technique of intralesional methylprednisolone injection (see Figure 3.1) 
 
Figure 3.1: Intralesional methylprednisolone injection 
 
 
 
 
The conjunctiva was anaesthetized with oxybuprocaine 0.4% (Novesine) drops. The 
conjunctival surface of the chalazion was then exposed by everting the eyelid or pulling 
the eyelid away from the globe with the aid of a cotton wool bud or finger. Next the 
chalazion was injected with 0.05 - 0.2 ml (2 – 8 mg, depending on lesion size) 
methylprednisolone acetate 40 mg/ml (Depo-Medrol) through the conjunctival surface 
with an insulin syringe. To avoid injury to the globe, the needle was always angled away 
from the globe when inserting the needle. There was no need to apply an eye pad  after 
the procedure.  
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Technique of incision and curettage (see Figure 3.2) 
 
Figure 3.2: Incision of a chalazion 
 
 
 
 
Oxybuprocaine 0.4% (Novesine) drops were instilled into the fornix, and the eyelid 
around the chalazion was infiltrated with a 2% lignocaine solution. Incision and curettage 
was done through a vertical conjunctival incision with the aid of a chalazion clamp, no.11 
surgical blade and a curette. Chloramphenicol ointment and an eye pad were applied after 
the procedure. Analgesia and topical chloramphenicol ointment were prescribed.  
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Main outcome measures 
 
These were the following: 
• Cure rate with each method at two weeks and one month after treatment 
• Lesion size after treatment 
• Number of treatments required for resolution 
• Influence of initial lesion size on outcome of treatment 
• Influence of lesion duration on outcome of treatment 
• Average time taken to perform each of the two procedures  
• Complications  
 
 
Statistical testing 
 
Sample size: From the literature it was assumed that a 90% success rate could be 
obtained using incision and curettage and a 60% cure rate for the injection group was 
considered feasible. The study was powered at 80% to detect a significant difference 
between the proportions of successful outcome in the groups with an α level of 0.05 and β 
of 0.2. The group size needed to be 38 in each group. 
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The following approach was used in selecting statistical tests: 
A level of significance of p less than or equal to 0.05 was considered significant.  
Before a Student’s t-Test (t test) was used the data were subjected to a Chi-square (non-
parametric) goodness-of-fit test and where the distribution was non-normal a non-
parametric test was used.  
Continuous variables were compared using t tests (Aspen-Welch if variance was not 
equal) for normally-distributed data or a two-sample Kolmogorov-Smirnov test where the 
data were not normally distributed. A Wilcoxon two-sample rank-sum (Mann-Whitney 
U) test was used where there was a non-normal distribution of data but variances were 
equal. 
For categorical data, a Chi-squared test was done followed by a two-sample test of 
proportions where necessary.  
Logistic regression was done with the outcome of resolution at 2 weeks and resolution at 
4 weeks controlling for initial chalazion size and testing all continuous and categorical 
variables for associations with resolution. Explanatory variables tested included initial 
size of chalazion, treatment method, age of patient, gender, number of treatments and 
duration of chalazion before treatment. 
 
Statistics were performed using the statistical software Stata version 8 (Stata Corporation, 
College station, Texas, USA). 
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4.0  RESULTS 
 
 
 
Seventy-three patients completed the study, while 4 were lost to follow-up. Thirty-seven 
patients received intralesional injection and 36 patients received incision and curettage. 
Patient age ranged from 16 to 67 years with an average age of 34.5 years. There was no 
significant difference in the mean age of males (34 years, 30 patients) compared with 
females (34.9 years, 43 patients). Thirty-seven chalazia were previously treated with 
conservative therapy while 36 cases did not receive any previous treatment. None of the 
chalazia was injected or incised before entering the study. 
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Table 4.1 contains demographic data of the two groups. 
 
 
Table 4.1: Demographic data of the two study groups 
 
 
 Intralesional 
methylprednisolone 
injection 
 
Incision and curettage 
Number of patients 
 
37 36 
p-value 
 
Average age 
 
32.7 36.4 0.190 a 
Gender: 
              male 
              female 
              % male 
 
15 
22 
40.5 
 
 
15 
21 
41.7 
 
 
 
0.922 b 
Race:  
          African 
          Mixed  
          Caucasian 
                
 
35 
1 
1 
 
34 
2 
0 
 
 
0.978 b 
Average initial 
chalazion size in mm 
 
 
8.5 
 
10.2 
 
0.004 a  
Average chalazion 
duration in months 
 
7.4 
 
5.4 
 
0.277 c 
 
 
Note: 
a  =  t test with equal variances 
b  =  two-sample test of proportions 
c  =  t test with unequal variances 
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The two groups were similar for number of patients, age, gender, race and average 
duration of the chalazia. The average initial chalazion size was smaller (p = 0.004) in the 
intralesional injection group (8.5 mm) than in the incision and curettage group (10.2 
mm). Table 4.2 contains treatment results for the two groups. 
 
 
Table 4.2: Treatment results for the two study groups 
 
 
 Intralesional 
methylprednisolone 
injection 
 
Incision and 
curettage 
p-value 
Resolution at two 
weeks  
 
 
10 (27%) 
 
 
23 (64%) 
 
0.002 b 
Resolution at one 
month 
 
 
24 (65%) 
 
28 (78%) 
 
0.223 b 
Chalazia that 
required two 
treatments to 
resolve 
 
 
 
14 (58%) 
 
 
5 (17.9%) 
 
 
0.020 b 
Average time in 
seconds to perform 
procedure 
 
 
39 
 
162 
 
0.000 c 
 
 
Note: 
 
b = two-sample test of proportions 
 
c = t test with unequal variances 
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At two weeks, after one treatment, the cure rate was significantly higher (p = 0.002) with 
incision and curettage. At one month however, there was no statistical difference in 
outcome (p = 0.223) between the two groups. In the successfully treated cases, a 
significantly higher number (p = 0.020) of chalazia required a second treatment with 
intralesional injection. The average time taken to perform intralesional injection was 
significantly shorter (p = 0.000) than the average time taken to perform incision and 
curettage. The following figures show successful as well as unsuccessful outcomes with 
the two methods. 
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Figure 4.1: A cure after intralesional injection 
 
 
   
                                               
 
Figure 4.1 A                                                            Figure 4.1 B 
Patient 21: Right upper lid chalazion                      Patient 21: Two weeks after treatment 
 
 
 
Figure 4.2: A cure after incision and curettage 
 
 
 
                
 
Figure 4.2 A                                                           Figure 4.2 B 
Patient 8: Left upper lid chalazion                         Patient 8: Two weeks after treatment       
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Figure 4.3: An unresolved chalazion after intralesional injection 
 
 
 
                
 
Figure 4.3 A                                                          Figure 4.3 B 
Patient 5: Left upper lid chalazion                        Patient 5: Chalazion smaller but not       
                                                                              completely resolved after two injections     
   
                                                                                
Figure 4.4: An unresolved chalazion after incision and curettage 
 
 
 
                 
 
Figure 4.4 A                                                            Figure 4.4 B 
Patient 66: Right upper lid chalazion                      Patient 66: Chalazion not completely 
                                                                                 resolved at month 1 
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Table 4.3 contains additional data for the two study groups. As the initial chalazion sizes 
were different between the two groups, this represents a confounder in the relationship 
between outcome (resolution) and various factors such as time to resolution and number 
of treatments required. To control for the effect of initial size of chalazion, logistic 
regression was performed and appears after the ‘Cure rates according to chalazion size’ 
results. 
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Table 4.3: Additional results for the two study groups 
 
 
 Intralesional 
methylprednisolone 
injection 
 
Incision and 
curettage 
Average initial chalazion size in mm 
Resolution at two weeks  
Resolution at one month 
No resolution 
 
 
8.00 
8.00 
9.46 
 
10.15 
10.30 
 9.75 
Unsuccessful outcomes                
Average initial chalazion size in mm  
Average chalazion size in mm, week 2  
Average chalazion size in mm, month 1  
                                      
 
9.46 
6.62 
5.46 
 
9.75 
6.25 
7.00 
Successful outcomes that needed two 
treatments 
Average initial chalazion size in mm 
Average chalazion size in mm, week two 
 
 
 
8.00 
5.57 
 
 
11.00 
 8.00 
Average chalazion duration in months 
Resolution at two weeks 
Resolution at one month 
No resolution 
                                                                     
 
10.4   
 7.5   
 7.3   
 
5.2   
5.6   
4.8   
Average age 
Resolution at two weeks 
Resolution at one month 
No resolution 
 
 
28.6   
32.8   
32.5   
 
36.4   
37.1   
34.0  
Percentage males 
Resolution at one month 
No resolution 
 
10/24 (41.7%) 
5/13 (38.5%) 
 
11/28 (39.3%) 
4/8 (50.0%) 
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In both groups, the average initial chalazion size and duration did not appear to influence 
the outcome of treatment at two weeks or one month.  
 
The mean size of chalazia in the intralesional injection group that did not resolve became 
less after treatment. There was on average a 30% decrease in chalazion size after one 
injection and a 42% decrease in size after two injections.  
 
Chalazia that did resolve with a second injection on average became 30% smaller after 
one injection. This was the same as for chalazia that did not resolve. 
 
Chalazia in the incision and curettage group that did not resolve also became smaller after 
treatment. There was on average a 36% decrease in mean chalazion size after one 
procedure and a 28% decrease in size after two procedures. 
 
Age and gender did not appear to have an influence on the outcome of treatment in both 
groups.  
 
No patients had associated acne rosacea. 
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Table 4.4 contains cure rates for small, medium and large chalazia. 
 
 
 
Table 4.4: Cure rates according to chalazion size 
 
 
 Small: < 7 mm Medium: 7-10 mm 
 
Large: > 10 mm 
 Intra- 
lesional 
injection 
 
Incision 
and 
curettage 
Intra- 
lesional 
injection 
Incision  
and  
curettage 
Intra- 
lesional 
injection 
Incision 
and  
curettage 
Number 
 
9 3 21 17 7 16 
Resolution at two 
weeks 
 
 
3 (33%) 
 
3 (100%) 
 
5 (24%) 
 
10 (59%) 
 
2 (29%) 
 
10 (63%) 
Resolution at one 
month 
 
7 (78%) 
 
3 (100%) 
 
13 (62%) 
 
12 (71%) 
 
4 (57%) 
 
13 (81%) 
 
 
There was no statistically significant difference in outcome at two weeks or one month 
between small, medium and large chalazia in both groups (two-sample test of 
proportions). 
 
 
Logistic regression 
 
For resolution at 4 weeks: After controlling for initial size, incision and curettage was 
more effective than injection (Odds ratio 2.1, p=0.178) while the two larger size 
categories, medium (Odds ratio 0.3, p=0.196) and large chalazia (Odds ratio 0.4, 
p=0.339) were less likely to resolve than small chalazia. 
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For resolution at 2 weeks: After controlling for initial size, incision and curettage was 
more effective than injection (Odds ratio 5.1, p=0.003) while the two larger size 
categories, medium (Odds ratio 0.4, p=0.248) and large chalazia (Odds ratio 0.4, 
p=0.278) were less likely to resolve than small chalazia. 
 
To summarize; logistic regression showed that after controlling for the confounder, initial 
size of chalazion, resolution at 2 weeks was significantly better using incision and 
curettage. It was also better at 4 weeks and larger chalazia were less likely to resolve 
although with the current group size these were not statistically significant. 
There were no other associations found with resolution.  
 
 
Complications 
 
In both groups the visual acuity and intraocular pressure remained stable after treatment. 
In 3 out of 37 injected chalazia, a slight subcutaneous methylprednisolone deposit was 
visible at one month after treatment. There were no other complications of treatment in 
both groups. 
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5.0  DISCUSSION 
 
 
The cure rate of 78% at one month with incision and curettage is in keeping with 
previous reports,(5; 6) but is lower than in a recent report where a 97% cure rate was 
achieved for 30 chalazia in African patients.(19) 
 
The cure rate of 65% at one month with intralesional methylprednisolone acetate           
40 mg/ml injection is lower than the cure rate of 86% that was reported in the previous 
study where intralesional methylprednisolone acetate 40 mg/ml was used in Caucasian 
patients.(7) It is also lower but comparable to the 80% cure rate in a previous report where 
intralesional triamcinolone 40 mg/ml was used in Caucasian patients.(9) 
 
Intralesional methylprednisolone injection in the treatment of chalazia has not previously 
been evaluated in African patients. In a study where intralesional triamcinolone   5 mg/ml 
was used to treat 25 chalazia in African patients,(11) the cure rate of 76% was higher but 
comparable to the cure rate in this study. A similar number of patients needed a second 
intralesional injection before resolution occurred.  
 
The cure rates with methylprednisolone injection at two weeks and one month are in 
general comparable to cure rates that were obtained with triamcinolone in previous 
studies. Possible reasons for different cure rates in different studies include racial 
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differences, a different concentration of medication used and a different definition of a 
successful outcome.  
 
In contrast to a previous report,(4)  the average initial chalazion size in both groups did not 
significantly influence the outcome of treatment. This is in agreement with another 
report. (13)  The initial chalazion size was, however, significantly different between the 
two groups; the incision and curettage group had a larger initial size (10.2mm) than the 
injection group (8.5mm). 
 
As initial size of the chalazion was a potential confounder, this was controlled for during 
logistic regression. This showed that incision and curettage was more likely to resolve the 
chalazion at 2 weeks (odds ratio 5.1) and also at 4 weeks (odds ratio 2.1). It also 
confirmed that resolution was less likely with the larger chalazions. 
 
As reported in previous studies,(9; 10; 13) the average duration of chalazia in the injection 
group did not influence the outcome of treatment. The same was true for the incision and 
curettage group. 
 
In both groups, patient age and gender did not influence the outcome of treatment. This is 
in keeping with a previous report. (9) 
 
No complications of treatment occurred in the incision and curettage group. In 3 out of 37 
injected patients, a slight subcutaneous methylprednisolone deposit was visible at one 
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month. These deposits were hardly noticeable and not a concern for the patients. In 
keeping with a previous report,(7) other possible complications of methylprednisolone 
injection like skin atrophy, skin depigmentation and increased intraocular pressure were 
not observed in this study. 
 
Patients with acne rosacea often have associated obstructive meibomian gland 
dysfunction and recurrent chalazia.(1) In a previous study in Caucasian patients,(9) 31 
patients (20%) with chalazia had associated acne rosacea. In this study where most 
patients were  Africans, there were no cases with associated acne rosacea. 
 
Intralesional injection was significantly quicker to perform than incision and curettage. It 
took on average 39 seconds to perform intralesional injection, compared to 2 minutes and 
42 seconds for incision and curettage. These times exclude the time it took to prepare for 
the procedures. It is quicker to prepare for intralesional injection, and time is also saved 
after the procedure because there is no need to apply an eye pad or to prescribe medicine. 
In keeping with previous studies, (3; 9; 11; 12; 13) two intralesional injections were often 
required to obtain a cure rate similar to that of incision and curettage. Although two 
injections will still be quicker to perform than one incision and curettage procedure, more 
patients treated with intralesional injection will have to return to the hospital for a second 
treatment. Although follow-up was good at our hospitals, it may be more problematic in 
rural areas where transport is not always readily available and many patients live further 
away from a hospital. Intralesional injection does not give an immediate cure which 
makes it a less attractive treatment option for some patients. 
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Both intralesional methylprednisolone injection and incision and curettage are cheap 
procedures, and there is not a significant difference in cost between these two treatment 
modalities. Both procedures are in general easy to perform. Some chalazia were more 
difficult to inject than others. There was marked resistance to injection in some of the 
cases. The amount of resistance to injection most likely correlates with the rigidity of the 
tarsal plate and the amount of fibrous tissue that surrounds the chalazion.(6) With more 
surrounding fibrous tissue or less granulomatous change in the tarsal plate there will most 
probably be more resistance to injection. In this study, most chalazia expanded readily 
with injection and were not difficult to treat. In some cases however, resistance to 
injection necessitated deeper placement of the needle with resultant extralesional or 
subcutaneous injection of the methylprednisolone.  
 
Leakage of methylprednisolone from the injection site or a meibomian gland orifice was 
also encountered in some of the cases. This may have caused  subtherapeutic amounts of 
methylprednisolone in some chalazia. 
 
Some chalazia contained no removable granulomatous tissue. Instead, a thickened and 
inflamed tarsal plate was present. Incision and curettage is usually not effective in these 
cases and an immediate intra or extralesional injection can be considered if no 
granulomatous tissue can be removed using incision and curettage. Chalazia treated with 
incision and curettage were generally not suitable for a second procedure at two weeks, 
due to the lack of removable granulomatous tissue. A chalazion that does not resolve 
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after a technically successful incision and curettage procedure may be well suited to 
injection to treat the residual swelling.  
 
If a chalazion does not respond to treatment, a tissue biopsy of the lesion should be 
examined histopathologically to exclude a sebaceous gland carcinoma. (20)  
 
The amount of pain experienced with intralesional as well as local anaesthetic injection 
was quite variable between patients. Some reported only slight discomfort while others 
experienced considerable pain.  
 
In this study, the final follow-up visit was at one month and recurrence rates with the two 
treatment modalities were not investigated. In previous studies, recurrence after 
intralesional triamcinolone 5 mg/ml injection occurred in 4,5% (10) and 17% (11) of cases. 
Recurrence after successful incision and curettage occurred in 3% of cases.(19) Another 
limitation of  this study was the absence of a conservative therapy treatment group. A  
77% and 25% cure rate have been reported after conservative therapy with hot 
compresses, lid scrubs and topical antibiotics.(21; 22)  
 
Possible considerations for future research would be to investigate the efficacy of 
conservative therapy for chalazia in our patient population and to follow patients up for a 
longer period of time. This may reveal possible recurrences after treatment and cases that 
may possibly resolve with more time or more than two injections.  
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6.0  CONCLUSION 
 
 
In this study, both intralesional methylprednisolone injection and incision and curettage 
proved to be safe and effective treatment modalities for chalazia. The results largely 
reflect the outcome in African patients, which comprised 95% of the study patients. 
 
Although intralesional injection was a simpler procedure, incision and curettage was a 
more effective method and remains the gold standard in the treatment of chalazia. This 
was also shown using logistic regression and controlling for the initial size of chalazia. 
 
However, intralesional methylprednisolone injection is an useful alternative method that 
some patients may prefer over incision and curettage. It is a repeatable procedure and 
may be especially useful in cases that are not ideally suited to incision and curettage, for 
example multiple small chalazia and cases with chronic diffuse meibomitis where there is 
a thickened, inflamed tarsal plate with no removable granulomatous tissue. Intra or 
extralesional injection may also be useful to treat persistent residual swelling after a 
technically successful incision and curettage procedure. An injection would be contra-
indicated if the chalazion shows any signs of infection or pus formation and also if the 
patient requires a quick cure. 
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Incision and curettage is the procedure of choice for chalazia that are infected or contain 
liquefied granulomatous tissue. It should also be done for chalazia that do not resolve 
after repeated injections and for patients that require an immediate cure.  
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8.0  ADDENDUM 
 
 
 
Inclusion criteria 
 
• Clinical diagnosis of a chalazion or multiple chalazia 
• Duration more than one month 
• No clinical signs of infection 
• Informed consent obtained 
 
 
 
Exclusion criteria 
 
• Previous treatment with surgery or injection 
 
 
 
 
